Annual Results Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Balance Sheet Analysis Highlights
Borrowings
No Borrowings in the last few periods;
Other Long Term Liabilities
YoY Growth in year ended Mar 2026 is 244.44% vs -70.00% in Mar 2025
Fixed Assets
No Fixed Assets in the last few periods;
Investments
No Investments in the last few periods;
Current Assets
YoY Growth in year ended Mar 2026 is 28.00% vs 373.63% in Mar 2025
Compare Balance Sheet Results of Biogen Pharma
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
90.26
5.01
85.25
1,701.60%
Share Warrants & Outstandings
Total Reserve
8.83
1.77
7.06
398.87%
Shareholder's Funds
99.09
6.78
92.31
1,361.50%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
0.00
0.00
0.00
0.00%
Secured Loans
0
0
0.00
0.00%
Unsecured Loans
0
0
0.00
0.00%
Deferred Tax Assets / Liabilities
0.00
-0.00
0.00
0.00%
Other Long Term Liabilities
0.31
0.00
0.31
0.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.00
0.47
-0.47
-100.00%
Total Non-Current Liabilities
0.00
0.20
-0.20
-100.00%
Current Liabilities
Trade Payables
0.00
0.07
-0.07
-100.00%
Other Current Liabilities
0.00
0.00
0.00
0.00%
Short Term Borrowings
0.00
0.00
0.00
0.00%
Short Term Provisions
0.00
0.47
-0.47
-100.00%
Total Current Liabilities
0.62
2.23
-1.61
-72.20%
Total Liabilities
99.40
8.54
90.86
1,063.93%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
0.00
0.04
-0.04
-100.00%
Less: Accumulated Depreciation
0.00
0.04
-0.04
-100.00%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
0.00
0.01
-0.01
-100.00%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
0.00
0.00
0.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0
0
0.00
0.00%
Long Term Loans & Advances
66.13
0.00
66.13
0.00%
Other Non Current Assets
0.00
0.00
0.00
0.00%
Total Non-Current Assets
0.00
0.03
-0.03
-100.00%
Current Assets Loans & Advances
Current Investments
32.78
0.00
32.78
0.00%
Inventories
0.00
0.00
0.00
0.00%
Sundry Debtors
0.00
0.00
0.00
0.00%
Cash and Bank
0.32
0.39
-0.07
-17.95%
Other Current Assets
0
0
0.00
0.00%
Short Term Loans and Advances
0.00
0.00
0.00
0.00%
Total Current Assets
33.10
0.39
32.71
8,387.18%
Net Current Assets (Including Current Investments)
32.48
-1.84
34.32
1,865.22%
Total Current Assets Excluding Current Investments
0.32
0.39
-0.07
-17.95%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
99.40
8.54
90.86
1,063.93%
Contingent Liabilities
0.00
0.00
0.00
0.00%
Total Debt
0.00
0.00
0.00
0.00%
Book Value per share (adjusted)
0.94
13.53
-12.59
-93.05%
Annual - Borrowings
No Borrowings in the last few periods
No Borrowings in the last few periods;
Annual - Other Long Term Liabilities
Other Long Term Liabilities 0.31 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 244.44% vs -70.00% in Mar 2025
Annual - Fixed Assets
No Fixed Assets in the last few periods
No Fixed Assets in the last few periods;
Annual - Investments
No Investments in the last few periods
No Investments in the last few periods;
Annual - Current Assets
Current Assets 33.10 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 28.00% vs 373.63% in Mar 2025
Footer loading
